Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: EIF5

Gene summary for EIF5

Gene summary.

Gene information	Species	Human
	Gene symbol	EIF5
	Gene ID	1983
	Gene name	eukaryotic translation initiation factor 5
	Gene Alias	EIF-5
	Cytomap	14q32.32
	Gene Type	protein-coding
	GO ID	GO:0001731
	UniProtAcc	A0A024R6Q1

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
1983	EIF5	P28T-E	Human	Esophagus	ESCC	9.67e-84	2.63e+00	0.1149
1983	EIF5	P30T-E	Human	Esophagus	ESCC	3.08e-57	2.82e+00	0.137
1983	EIF5	P31T-E	Human	Esophagus	ESCC	8.03e-87	2.37e+00	0.1251
1983	EIF5	P32T-E	Human	Esophagus	ESCC	1.36e-62	2.30e+00	0.1666
1983	EIF5	P36T-E	Human	Esophagus	ESCC	6.15e-31	1.61e+00	0.1187
1983	EIF5	P37T-E	Human	Esophagus	ESCC	1.27e-41	1.50e+00	0.1371
1983	EIF5	P38T-E	Human	Esophagus	ESCC	8.69e-08	7.36e-01	0.127
1983	EIF5	P39T-E	Human	Esophagus	ESCC	2.21e-27	1.08e+00	0.0894
1983	EIF5	P40T-E	Human	Esophagus	ESCC	1.86e-24	1.30e+00	0.109
1983	EIF5	P42T-E	Human	Esophagus	ESCC	1.69e-50	2.20e+00	0.1175
1983	EIF5	P44T-E	Human	Esophagus	ESCC	2.51e-15	9.32e-01	0.1096
1983	EIF5	P47T-E	Human	Esophagus	ESCC	1.52e-51	1.87e+00	0.1067
1983	EIF5	P48T-E	Human	Esophagus	ESCC	1.27e-50	1.38e+00	0.0959
1983	EIF5	P49T-E	Human	Esophagus	ESCC	3.18e-25	3.79e+00	0.1768
1983	EIF5	P52T-E	Human	Esophagus	ESCC	2.94e-35	1.48e+00	0.1555
1983	EIF5	P54T-E	Human	Esophagus	ESCC	4.91e-69	2.37e+00	0.0975
1983	EIF5	P56T-E	Human	Esophagus	ESCC	1.37e-23	2.53e+00	0.1613
1983	EIF5	P57T-E	Human	Esophagus	ESCC	8.05e-39	1.44e+00	0.0926
1983	EIF5	P61T-E	Human	Esophagus	ESCC	2.17e-60	3.17e+00	0.099
1983	EIF5	P62T-E	Human	Esophagus	ESCC	5.93e-92	2.32e+00	0.1302

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Breast		IDC: Invasive ductal carcinoma
		DCIS: Ductal carcinoma in situ
		Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers
Cervix		CC: Cervix cancer
		HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions
		N_HPV: HPV-infected normal cervix
Colorectum (GSE201348)		FAP: Familial adenomatous polyposis
		CRC: Colorectal cancer
Colorectum (HTA11)		AD: Adenomas
		SER: Sessile serrated lesions
		MSI-H: Microsatellite-high colorectal cancer
		MSS: Microsatellite stable colorectal cancer
Endometrium		AEH: Atypical endometrial hyperplasia
		EEC: Endometrioid Cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Lung		AAH: Atypical adenomatous hyperplasia
		AIS: Adenocarcinoma in situ
		IAC: Invasive lung adenocarcinoma
		MIA: Minimally invasive adenocarcinoma
Oral Cavity		EOLP: Erosive Oral lichen planus
		LP: leukoplakia
		NEOLP: Non-erosive oral lichen planus
		OSCC: Oral squamous cell carcinoma
Prostate		BPH: Benign Prostatic Hyperplasia
Skin		AK: Actinic keratosis
		cSCC: Cutaneous squamous cell carcinoma
		SCCIS:squamous cell carcinoma in situ
Thyroid		ATC: Anaplastic thyroid cancer
		HT: Hashimoto's thyroiditis
		PTC: Papillary thyroid cancer

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:00021819	Breast	Precancer	cytoplasmic translation	80/1080	148/18723	1.59e-59	8.54e-56	80
GO:00226139	Breast	Precancer	ribonucleoprotein complex biogenesis	79/1080	463/18723	2.11e-18	1.03e-15	79
GO:00971939	Breast	Precancer	intrinsic apoptotic signaling pathway	59/1080	288/18723	8.07e-18	3.60e-15	59
GO:20012339	Breast	Precancer	regulation of apoptotic signaling pathway	65/1080	356/18723	7.70e-17	3.17e-14	65
GO:20012429	Breast	Precancer	regulation of intrinsic apoptotic signaling pathway	41/1080	164/18723	6.48e-16	2.31e-13	41
GO:00718269	Breast	Precancer	ribonucleoprotein complex subunit organization	48/1080	227/18723	2.68e-15	8.45e-13	48
GO:00226189	Breast	Precancer	ribonucleoprotein complex assembly	47/1080	220/18723	3.47e-15	1.03e-12	47
GO:00064138	Breast	Precancer	translational initiation	30/1080	118/18723	3.23e-12	5.58e-10	30
GO:00064179	Breast	Precancer	regulation of translation	67/1080	468/18723	4.71e-12	7.64e-10	67
GO:00457279	Breast	Precancer	positive regulation of translation	32/1080	136/18723	5.89e-12	9.27e-10	32
GO:00342509	Breast	Precancer	positive regulation of cellular amide metabolic process	33/1080	162/18723	1.72e-10	1.77e-08	33
GO:20012445	Breast	Precancer	positive regulation of intrinsic apoptotic signaling pathway	17/1080	58/18723	1.59e-08	1.12e-06	17
GO:00064466	Breast	Precancer	regulation of translational initiation	19/1080	79/18723	7.99e-08	4.60e-06	19
GO:20012356	Breast	Precancer	positive regulation of apoptotic signaling pathway	24/1080	126/18723	1.98e-07	1.01e-05	24
GO:19017989	Breast	Precancer	positive regulation of signal transduction by p53 class mediator	10/1080	25/18723	5.77e-07	2.49e-05	10
GO:19017969	Breast	Precancer	regulation of signal transduction by p53 class mediator	19/1080	93/18723	1.20e-06	4.60e-05	19
GO:00021838	Breast	Precancer	cytoplasmic translational initiation	11/1080	34/18723	1.87e-06	6.63e-05	11
GO:00723319	Breast	Precancer	signal transduction by p53 class mediator	26/1080	163/18723	2.23e-06	7.76e-05	26
GO:00723328	Breast	Precancer	intrinsic apoptotic signaling pathway by p53 class mediator	16/1080	76/18723	5.49e-06	1.63e-04	16
GO:00017328	Breast	Precancer	formation of cytoplasmic translation initiation complex	7/1080	16/18723	1.50e-05	3.71e-04	7

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50

Enriched KEGG pathways.

Pathway ID

Tissue

Disease Stage

Description

Gene Ratio

Bg Ratio

pvalue

p.adjust

qvalue

Count

Page: 1

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand

Receptor

LRpair

Pathway

Tissue

Disease Stage

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

Cell Type

Tissue

Disease Stage

Target Gene

RSS

Regulon Activity

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

EIF5

SNV

Missense_Mutation

c.39C>G

p.Phe13Leu

p.F13L

P55010

protein_coding

deleterious(0.03)

possibly_damaging(0.558)

TCGA-A2-A0YL-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Chemotherapy

cytoxan

EIF5

SNV

Missense_Mutation

c.238C>T

p.His80Tyr

p.H80Y

P55010

protein_coding

deleterious(0)

benign(0.277)

TCGA-A2-A0YL-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Chemotherapy

cytoxan

EIF5

SNV

Missense_Mutation

rs779336285

c.124G>A

p.Val42Ile

p.V42I

P55010

protein_coding

tolerated(0.55)

benign(0.013)

TCGA-D8-A1JD-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

adriamycin

EIF5

SNV

Missense_Mutation

c.33N>G

p.Asp11Glu

p.D11E

P55010

protein_coding

deleterious(0)

possibly_damaging(0.87)

TCGA-E2-A14O-01

Breast

breast invasive carcinoma

Female

>=65

III/IV

Hormone Therapy

arimidex

EIF5

insertion

In_Frame_Ins

novel

c.321_322insTGTCTTGCAGCTTATTCGCCTCAT

p.Thr107_Asp108insCysLeuAlaAlaTyrSerProHis

p.T107_D108insCLAAYSPH

P55010

protein_coding

TCGA-A7-A0CE-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

adriamycin

EIF5

insertion

Nonsense_Mutation

novel

c.507_508insCGAGGTCAGGAGTTCTAGACCAGCCTAGCCAACAT

p.Asn170ArgfsTer6

p.N170Rfs*6

P55010

protein_coding

TCGA-A8-A09W-01

Breast

breast invasive carcinoma

Female

>=65

III/IV

Unknown

EIF5

insertion

Nonsense_Mutation

novel

c.311_312insCGTCTGATTGCCAAGGTAATAAACTGCTCTTCAATTTAGT

p.Pro105ValfsTer2

p.P105Vfs*2

P55010

protein_coding

TCGA-A8-A09X-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Unknown

EIF5

SNV

Missense_Mutation

novel

c.1204N>A

p.Glu402Lys

p.E402K

P55010

protein_coding

deleterious(0.02)

benign(0.173)

TCGA-C5-A1MN-01

Cervix

cervical & endocervical cancer

Female

<65

III/IV

Chemotherapy

cisplatin

EIF5

SNV

Missense_Mutation

novel

c.89N>G

p.Asn30Ser

p.N30S

P55010

protein_coding

deleterious(0)

probably_damaging(0.946)

TCGA-MA-AA3Z-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Unknown

EIF5

SNV

Missense_Mutation

novel

c.173N>T

p.Gly58Val

p.G58V

P55010

protein_coding

deleterious(0)

benign(0.267)

TCGA-VS-A9V5-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Chemotherapy

carboplatin

Page: 1 2 3 4 5 6

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID

Symbol

Category

Interaction Types

Drug Claim Name

Drug Name

PMIDs

Page: 1